APA (7th ed.) Citation

Lee, J. H., Ahn, J., Kang, D., Kim, K. W., Koo, H. J., Yang, D. H., . . . Park, D. (2023). Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial. The American Journal of Cardiology, 203, 352-361. https://doi.org/10.1016/j.amjcard.2023.06.018

Chicago Style (17th ed.) Citation

Lee, Jeen Hwa, et al. "Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial." The American Journal of Cardiology 203 (2023): 352-361. https://doi.org/10.1016/j.amjcard.2023.06.018.

MLA (9th ed.) Citation

Lee, Jeen Hwa, et al. "Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial." The American Journal of Cardiology, vol. 203, 2023, pp. 352-361, https://doi.org/10.1016/j.amjcard.2023.06.018.